Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
University of Sydney
Sídney, AustraliaPublicaciones en colaboración con investigadores/as de University of Sydney (11)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
-
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4
-
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases
Matrix Biology, Vol. 132, pp. 1-9
2022
-
SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin
Frontiers in Pharmacology, Vol. 13
2019
-
Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide
Clinical Gastroenterology and Hepatology, Vol. 17, Núm. 11, pp. 2320-2329.e12
2018
-
Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis
Journal of Hepatology, Vol. 69, Núm. 2, pp. 396-405
2017
-
Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks
Neuroscience and Biobehavioral Reviews, Vol. 76, pp. 380-395
2015
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
2014
-
Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Journal of Translational Medicine, Vol. 12, Núm. 1